Browsing Tag
Nature Communications
1 post
Rein’s $57.5m financing buys LTI-03 time, but Phase 2 IPF data now carry the valuation
LTI-03 wins FDA Fast Track status as Rein deploys its $43.6m cash position behind a closely watched Phase 2 IPF readout due in 2026.